Overview

Role of Active Deresuscitation After Resuscitation:

Status:
NOT_YET_RECRUITING
Trial end date:
2025-06-30
Target enrollment:
Participant gender:
Summary
The RADAR-Canada trial is a pilot RCT undertaken to assess the acceptability of, compliance with, and biologic consequences of a deresuscitation protocol designed to expedite the removal of excess interstitial fluid in patients who remain in a positive fluid balance following admission to an intensive care unit (ICU).
Phase:
PHASE2
Details
Lead Sponsor:
Unity Health Toronto
Collaborator:
Canadian Institutes of Health Research (CIHR)
Treatments:
Furosemide
Metolazone